te Zydus Lifesciences gets USFDA nod to its generic medicine for high blood pressure | Zee Business

Zydus Lifesciences gets USFDA nod to its generic medicine for high blood pressure

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture and market its generic version of metoprolol tartrate tablets used to treat high blood pressure.

Zydus Lifesciences gets USFDA nod to its generic medicine for high blood pressure
The drug will be manufactured at the group's formulation manufacturing facility at Baddi in Himachal Pradesh. Pic: Reuters

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture and market its generic version of metoprolol tartrate tablets used to treat high blood pressure. The approval granted by the United States Food and Drug Administration (USFDA) is for metoprolol tartrate tablets of strengths 25 mg, 50 mg, and 100 mg, Zydus Lifesciences said in a regulatory filing.

The drug will be manufactured at the group's formulation manufacturing facility at Baddi in Himachal Pradesh, it added.

Also Read: Tata Communications Q4 profit dips about 11% to Rs 326 crore

TRENDING NOW

Metoprolol is used with or without other medications to treat high blood pressure (hypertension), the company said, adding the medication is also used to treat chest pain (angina) and to improve survival after a heart attack.

Metoprolol tartrate tablets 25 mg, 50 mg, and 100 mg had annual sales of USD 45.2 million in the US, the company said citing IQVIA MAT February 2023 data.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.

Written By: PTI
Updated: Thu, Apr 20, 2023
01:04 pm
PTI
RELATED NEWS
Nokia Q4 operating profit down 27%, beats forecast on margin boost Nokia Q4 operating profit down 27%, beats forecast on margin boost
Walt Disney and Mahindra officials join USISPF Board of Directors Walt Disney and Mahindra officials join USISPF Board of Directors
Go First's lenders seek investor bids by January 31 -sources Go First's lenders seek investor bids by January 31 -sources
GD Goenka Group appoints Gaurav Himkar as Group CEO GD Goenka Group appoints Gaurav Himkar as Group CEO
CureBay raises Rs 62 crore from Elevar, others CureBay raises Rs 62 crore from Elevar, others

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x